Antibiotics for community-acquired pneumonia in children
Sushil K Kabra1, Rakesh Lodha, Ravindra M Pandey
1Pediatric Pulmonology Division, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India, 110029.
Insights
Amoxycillin is an effective treatment for childhood community-acquired pneumonia (CAP), comparable to co-trimoxazole for non-severe cases. For severe CAP, penicillin/ampicillin plus gentamycin is superior to chloramphenicol.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Bacterial pneumonia is a leading cause of child mortality in low-income countries.
- Early antibiotic administration is crucial for improving outcomes in pediatric pneumonia.
Purpose of the Study:
- To compare the effectiveness of various antibiotics for treating community-acquired pneumonia (CAP) in children.
- To identify optimal antibiotic strategies for different severities of pediatric CAP.
Main Methods:
- Systematic review of randomized controlled trials (RCTs) identified through comprehensive database searches (CENTRAL, MEDLINE, EMBASE).
- Data extraction by two independent reviewers from 27 RCTs involving 11,928 children.
- Comparison of antibiotic efficacy based on failure rates, cure rates, and mortality.
Main Results:
- Amoxycillin showed similar efficacy to co-trimoxazole for ambulatory, non-severe CAP.
- Oral amoxycillin demonstrated comparable outcomes to injectable penicillin/ampicillin for hospitalized severe CAP.
- Penicillin/ampicillin plus gentamycin was associated with lower mortality than chloramphenicol in very severe CAP.
Conclusions:
- Amoxycillin is a viable alternative to co-trimoxazole for non-severe CAP.
- Penicillin/ampicillin plus gentamycin is the preferred treatment for severe and very severe CAP over chloramphenicol.
- Further research with larger populations is needed to evaluate newer antibiotics and optimize treatment guidelines for pediatric CAP.
Background:
Pneumonia caused by bacterial pathogens is the leading cause of mortality in children in low-income countries. Early administration of antibiotics improves outcomes.
Objectives:
To identify effective antibiotics for community acquired pneumonia (CAP) in children by comparing various antibiotics.
Search Strategy:
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2009, issue 2) which contains the Cochrane Acute Respiratory Infections Group's Specialised Register; MEDLINE (1966 to September 2009); and EMBASE (1990 to September 2009).
Selection Criteria:
Randomised controlled trials (RCTs) in children of either sex, comparing at least two antibiotics for CAP within hospital or ambulatory (outpatient) settings.
Data Collection And Analysis:
Two review authors independently extracted data from full articles of selected studies.
Main Results:
There were 27 studies, which enroled 11,928 children, comparing multiple antibiotics. None compared antibiotic with placebo.For ambulatory treatment of non-severe CAP, amoxycillin compared with co-trimoxazole had similar failure rates (OR 0.92; 95% CI 0.58 to 1.47) and cure rates (OR 1.12; 95% CI 0.61 to 2.03). (Three studies involved 3952 children).In children hospitalised with severe CAP, oral amoxycillin compared with injectable penicillin or ampicillin had similar failure rates (OR 0.95; 95% CI 0.78 to 1.15). (Three studies involved 3942 children). Relapse rates were similar in the two groups (OR 1.28; 95% CI 0.34 to 4.82).In very severe CAP, death rates were higher in children receiving chloramphenicol compared to those receiving penicillin/ampicillin plus gentamycin (OR 1.25; 95% CI 0.76 to 2.07). (One study involved 1116 children).
Authors' Conclusions:
There were many studies with different methodologies investigating multiple antibiotics. For treatment of ambulatory patients with CAP, amoxycillin is an alternative to co-trimoxazole. With limited data on other antibiotics, co-amoxyclavulanic acid and cefpodoxime may be alternative second-line drugs. For severe pneumonia without hypoxia, oral amoxycillin may be an alternative to injectable penicillin in hospitalised children; however, for ambulatory treatment of such patients with oral antibiotics, more studies in community settings are required. For children hospitalised with severe and very severe CAP, penicillin/ampicillin plus gentamycin is superior to chloramphenicol. The other alternative drugs for such patients are ceftrioxone, levofloxacin, co-amoxyclavulanic acid and cefuroxime. Until more studies are available, these can be used as a second-line therapy.There is a need for more studies with larger patient populations and similar methodologies to compare newer antibiotics.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:29Pneumonia I: Introduction
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:14Atypical Pneumonia